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Abstract:The American Society of Transplantation Infectious
Diseases (ID) Community of Practice has established an education
workgroup to identify core components of a curriculum for training
specialists in transplant ID. Clinical, laboratory, and research training
form the triad of components onwhich an additional year of ID training,
dedicated to the care of solid organ and hematopoietic stem cell
transplant recipients, should be based.The recommended training
environment would have access to adequate numbers of transplant
patients, along with quali¢ed faculty committed to teaching specialized
fellows in this area.The learning objectives for both inpatient and
outpatient clinical training are presented.The laboratory component
requires trainees to attain expertize in utilizing and interpreting
cutting-edge diagnostics used in transplant medicine.The research
component may involve basic science, and translational or clinical
research individualized to the trainee. Finally, suggestions for
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The subspecialty of Transplant Infectious Disease (ID)
represents a unique knowledge base that di¡ers from ‘gen-
eral’ ID. ID fellows who wish to pursue a career path in
which a signi¢cant portion of their duties includes the care
of the transplant patient should pursue additional training
in transplant ID.The American Society of Transplantation
(AST) ID Community of Practice has developed the follow-
ing set of recommendations that outline the key compo-
nents of an adult transplant ID fellowship program, which
can be further adapted for pediatric-speci¢c training.This
curriculum is based on a document originally developed by
Drs Robin Avery and Jay Fishman for training fellows in
transplant ID, which has been modi¢ed by the AST ID
Community of Practice Educational Initiatives Working
Group.
Training program
Duration of recommended training program
The minimum recommended duration of additional train-
ing to attain clinical competence in the ¢eld of transplant
ID is 1year.This training is to be pursued after the trainee
has completed his/her basic training in general ID. The
duration of transplant ID training, however, will vary
based upon the speci¢c goals of the trainee, particularly if
research is a major career goal.
Training environment
It is recognized that transplant programs vary widely in
terms of types of transplant procedures performed, volume
of transplantation, and clinical practices. The following
environment is preferred to ensure comprehensive training
of the fellow:
 An active multi-organ transplant program with su⁄-
cient volume to allow the trainee to see common oppor-
tunistic pathogens observed in these patients, and an
active allogeneic hematopoietic stem cell transplant
(HSCT) program is preferred.
 Fewer centers have large lung transplant programs,
and training in this area may therefore be more di⁄-
cult to achieve. Because lung transplant and HSCTpa-
tients are often at the greatest risk for infectious
complications, periods of elective training should be
considered at another center, if such training is not
available at the primary training site.
 The center should have at least 1 physician (and prefer-
ably a group of physicians) with clear expertise in
transplant ID to ensure adequate mentorship.
 The center should have established didactic and case-
based interactive teaching conferences that encourage
trainee participation and that encompass both clinical
and research educational objectives.
Components
Major components
Three major components are recommended for a 1-year
standard training curriculum in transplant ID.
(1) Clinical training (24 week minimum).
(2) Laboratory training (2^4 week minimum).
(3) Research training (12^20 weeks).
Additional training components
In addition to the clinical, laboratory, and research training,
standard training competencies in practice-based learning,
professionalism, ethics, and systems development related
to transplant ID should be demonstrated. The program
should assess the following objectives:
 Practice-based learning:
 Develop knowledge of fundamental resources including,
but not limited to, the AST Transplant ID guidelines,
evidence-based medicine databases, and additional
guidelines from other critical sources. A list of key refer-
ences and supplementary teaching materials, developed
by theAST ID Communityof Practice, is available on the
internet (http://www.a-s-t.org/index.cfm).
 Utilize these resources to participate in case-based
learning with transplant ID faculty.
 Professionalism/communication:
 Develop skills to interact appropriately with patients
and families while respecting patient con¢dentiality.
 Demonstrate cooperative team building with all mem-
bers of the transplant team including nurses, coordina-
tors, data managers, and physicians/surgeons.
 Understand how the transplant ID physician interacts
with the multi-disciplinary transplant team.
 The trainee should come to understand that transplant
ID forms an integral component of the transplant pro-
gram and transplant-related care.
 Ethics:
 Understand the processes of consent, donor, and recip-
ient selection (including issues of brain death and do-
nation after cardiac death), allocation systems, and
considerations regarding re-transplantation and lim-
ited resource utilization.
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 Systems development:
 In the United States, understand the structure and
function of OPTN/UNOS, OPOs, and the National
Marrow Donor Program (in Canada, the Stem Cell and
Marrow Network).
 Develop an understanding for the need and methods to
increase donation at large and in minority groups.
Detailed description of core components
Clinical training. The clinical component of training should
include both inpatient and outpatient care. The clinical
training should be focused on transplant patients (solid or-
gan transplant [SOT], HSCT) including pre-transplant as-
sessment and peri-operative and post-transplantation care.
Training programs may also encompass ID care for pa-
tients immunocompromised on the basis of cancer chemo-
therapy. Care of other immunocompromised hosts, such as
patients with human immunode¢ciency virus, should not
be a signi¢cant focus of training unless transplant-related.
Inpatient clinical service. Inpatient clinical service is the core
of the transplant ID training program.The duration of in-
patient service commitments will vary depending on the
career goals of the fellow, but a minimum of 24 weeks is
recommended. Clinical encounters should occur on inpa-
tient wards, intensive care units, and the emergency de-
partment. Each case should be reviewed by the attending
physicians, and important learning points highlighted
and discussed on a case-by-case basis. Fellows should be
expected to provide longitudinal follow-up of patients
along with the attending physicians. Independent decision
making and problem solving should be encouraged. Med-
ical decision making should take into account relevant
¢ndings (Gram stain, preliminary culture results, molecu-
lar diagnostic assays, pathology and imaging results, etc.)
from the Clinical Microbiology Laboratory, and the Pathol-
ogy and Radiology Departments.
Outpatient clinic. The fellow should have an outpatient com-
ponent to clinical training.This requirement is more £exi-
ble, but preferably should be 1 or 2 longitudinal half-day




(1) Understand how transplant ID ¢ts into the global con-
text of transplant care, from pre-transplant workup
and transplant selection committees, to donor evalua-
tion and peri-operative care, to post-transplant man-
agement.
(2) Understand immunosuppression, and how speci¢c im-
munosuppressive agents contribute to the net state
immunosuppression. This includes knowledge of im-
munosuppressive mechanisms of action, drug interac-
tions with anti-infectives including enhanced toxicity
with some combinations of antimicrobials and immu-
nosuppressives, evolving assays to assess immune
function, and infectious risk with enhanced immuno-
suppression related to induction therapy or treatment
of rejection.
(3) Identify the major pathogens of opportunistic and
other common infections as well as the major clinical
syndromes that occur in SOTand HSCT recipients.
(4) Understand the principal diagnostic modalities includ-
ing radiology, microbiology (including molecular and
immunologic diagnostic assays), and histopathology,
along with the most e¡ective application and limita-
tions of each in this patient population.
(5) Understand strategies for prevention of infection in
these patients including the use of prophylactic and
preemptive strategies.
(6) Understand the principles of treatment of infections in
these patients, and how these patients di¡er from non-
immunocompromised hosts in terms of therapeutic re-
sponse and therapeutic urgency.
(7 ) Become comfortable in dealing with life-threatening
infections and critically ill transplant patients and
their families.
Speci¢c objectives: SOT
 Describe the approach to and treatment of common
infections observed in patients with end-stage organ
failure. Speci¢cally, this includes, but is not limited to:
 infections related to dialysis access in patients with
end-stage renal disease,
 spontaneous bacterial peritonitis and hepatitis B and C
in patients with liver failure,
 exacerbations of cystic ¢brosis in patients awaiting
lung transplantation,
 infections related to mechanical circulatory support in-
cluding extracorporeal membrane oxygenation and
ventricular assist devices in cardiac transplant candi-
dates.
 Perform complete pre-transplantation evaluations.The
fellow should understand the risks for infection after
transplant based on epidemiology and personal his-
tory, and communicate these risks to potential recipi-
ents. This workup should include an evaluation of the
need for immunization using medical history and/or
laboratory data.
Avery et al: TID training curriculum
192 Transplant Infectious Disease 2010: 12: 190^194
 Have a clear approach to common donor-related ID and
current laboratory evaluation techniques for poten-
tially transmissible infections in donors. In the United
States, understand the reporting requirements of do-
nor-transmitted infections.
 Describe technical complications and infectious se-
quelae that mayoccur as a result of such complications.
The trainee should have a £uent understanding of the
anatomy related to the transplant procedure. The trai-
nee should have a clear understanding of the incidence,
risk factors, timing, and presentations of vascular and
non-vascular technical complications related to each
transplant procedure.
 Appreciate the risks associated with hospitalization at
transplant, including but not limited to infection con-
trol and prevention policies, hand hygiene, surgical site
infections, and nosocomial infections related to instru-
mentation.
 Understand the approach to the transplant patient with
fever and no localizing signs. This approach includes
use of appropriate imaging and laboratory diagnostics.
 For disease-speci¢c presentations, understand the ap-
propriate medical history including potential expo-
sures, physical examination, imaging, and laboratory
diagnostics. Commonly encountered diseases that
should be covered include viral infections (cytome-
galovirus [CMV], Epstein^Barr virus [EBV], varicella
zoster virus [VZV], other herpesviruses, BK virus,
hepatitis viruses, and community-acquired respira-
tory viruses), mycobacterial infections (tuberculosis,
non-tuberculous mycobacteria), fungal infections
(Candida, Aspergillus, and rare molds), and bacterial
infections (including emerging multi-drug resistant
bacteria: Pseudomonas, carbapenem-resistant Klebsiel-
la pneumoniae, Acinetobacter baumannii, methicillin-
resistant Staphylococcus aureus, and vancomycin-resis-
tant Enterococcus).
 Perform comprehensive follow-up for infectious epi-
sodes in the outpatient setting.
 Understand outpatient evaluation for transplant recip-
ients planning travel and the need for continued review
of immunization status after transplantation.
Speci¢c objectives: HSCT/oncology
 Demonstrate understanding of the pre-transplantation
clinical assessment, including risk based on HSCTmo-
dality (myeloablative vs. reduced-intensity, allogeneic
vs. autologous, related, unrelated, and cord blood do-
nors), and donor assessment including vaccination
and disquali¢cation.
 Exhibit understanding of peri-transplant prophylaxis
strategies in the induction, neutropenic, and early en-
graftment phases.
 Appreciate the risks associated with hospitalization at
transplant, including but not limited to infection con-
trol and prevention policies, hand hygiene, surgical site
infections, and infection related to instrumentation.
 Discuss the diagnosis and management of early post-
transplant infectious complications including viral in-
fections (CMV, EBV, VZV, other herpesviruses, BK vi-
rus, adenovirus, and community-acquired respiratory
viruses), fungal infections (Candida, Aspergillus, and
rare molds), and bacterial infections (including emerg-
ing multi-drug-resistant bacteria).
 Demonstrate understanding of late post-transplant
complications including graft-versus-host disease and
autoimmune diseases.
 Appreciate the di⁄culty in discerning graft-versus-
host disease from infection in this population.
 Describe the recommendations and rationale for revac-
cination after HSCT.
Laboratory component
Modern laboratory methods, speci¢cally molecular diag-
nostics, are a key component of transplant ID practice and
training.The trainee should spend time in a modern molec-
ular diagnostic laboratory that services the transplant pop-
ulation. The trainee should understand the methodology,
interpretations, and limitations of molecular testing for
pathogens, speci¢cally CMV, EBV, and BKvirus.
Objectives
 To attain a basic understanding of laboratory tech-
niques that are fundamental to transplant virology, in-
cluding sterile technique, centrifuging, pipetting,
running gels, making media, ¢ltering, maintenance of
cell lines in tissue culture media; microscopy of cul-
tured cells; propagation of herpesviruses in tissue cul-
ture; and recognition of cytopathic e¡ects.
 To attain a basic understanding of techniques impor-
tant to immune function and phenotype assays, includ-
ing £ow cytometry, cell proliferation assays, antigen
stimulation, interferon-gamma (IFN-g) production
and enzyme-linked immunosorbent spot (ELISPOT)
assays, and immunohistochemistry.
 To achieve a detailed understanding of molecular
methods used to diagnose viral infections (CMV, EBV,
BKV, respiratory viruses) in SOT/HSCT patients, in-
cluding the use of positive/negative controls, assay
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variability, appropriate specimens for testing, and clin-
ical interpretation of results.
Research training: translational, basic, and clinical
research (individualized)
The research training should be focused on the individual
goals of the fellow and may incorporate additional time be-
yond the core year of training to complete more advanced
research training. Depending on the goals, research may be
basic, translational, or clinical in nature.
 Basic science training may involve mastering labora-
tory techniques that are fundamental to transplant ID
including sterile technique, centrifuging, pipetting,
running gels, making media, and ¢ltering. Additional
virology techniques could include maintenance of cell
lines in tissue culture media and microscopy of cul-
tured cells, propagation of herpesviruses in tissue cul-
ture, and recognition of cytopathic e¡ects. Upon
mastering these skills, they would be applied to an ap-
propriate research project developed in conjunction
with and supervised by the attending physicians.
 Translational research may include mastering the
techniques above as well as techniques to assess im-
mune function and phenotype assays, such as £ow
cytometry, cell proliferation assays, antigen stimula-
tion, IFN-g production and ELISPOT assays, and
immunohistochemistry. Upon mastering these skills,
they would be applied to an appropriate research proj-
ect developed in conjunction with and supervised by
the attending physicians.
 Clinical research may include designing and complet-
ing a high-quality retrospective chart or database re-
view of a crucial and under-reported topic in
transplant ID or a high-quality systematic review of a
crucial and under-reported topic in transplant ID.
Objectives
 All fellows should have training in the design, imple-
mentation, data collection, analysis, and reporting of
a basic-translational study with relevance to trans-
plant infections.
 An abstract should be submitted for presentation at a
national/international transplant ID-related meeting.
A summary manuscript should be drafted and, ideally,
submitted for publication. Attendance at a transplant
ID-related meeting is strongly encouraged.
Evaluation
At the end of each rotation (monthly), oral or written evalu-
ation by the transplant ID sta¡ physician or laboratory/re-
search supervisor should include an assessment of all
standard training competencies (knowledge, practice-
based learning, professionalism, ethics, and systems devel-
opment) as related to transplant ID.
} Optimally, multi-source feedback on inter-profes-
sional, collaborator, and communication skills should
be sought from transplant ID sta¡ as well as all mem-
bers of the multi-disciplinary transplant team.
 Knowledge and knowledge application should be as-
sessed at or before the midpoint of training, using oral
or written examinations, including a series of short-
answer questions available on the ASTwebsite.
 Feedback should be sought from the fellow on the
transplant ID training program, transplant ID sta¡,
and advisors.
Summary
This curriculum serves to provide comprehensive guide-
lines for training fellows in transplant ID.These guidelines
will no doubt need to be modi¢ed for the unique environ-
ment of each transplant center. Moreover, as the ¢eld
changes and new paradigms in transplantation emerge,
updates will be required as well.
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